The effects of cryopreservation on red blood cell microvesiculation, phosphatidylserine externalization, and CD47 expression

Transfusion

Volumn 48, Issue 8, 2008, Pages 1658-1668

  Holovati, Jelena L ^b   Wong, Kenneth A ^b   Webster, Jarret M ^b   Acker, Jason P ^a  

^a CANADIAN BLOOD SERVICES   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN; GLYCEROL; PHOSPHATIDYLSERINE;

ANTIGEN EXPRESSION; ARTICLE; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; ERYTHROCYTE LIFESPAN; ERYTHROCYTE PRESERVATION; ERYTHROCYTE STRUCTURE; FLOW CYTOMETRY; HEMOLYSIS; HUMAN; NORMAL HUMAN; QUALITY CONTROL;

ANTIGENS, CD47; BIOLOGICAL MARKERS; BLOOD PRESERVATION; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; CYTOPLASMIC VESICLES; ERYTHROCYTES; FLOW CYTOMETRY; GLYCEROL; HEMOLYSIS; HUMANS; PHOSPHATIDYLSERINES;

EID: 48249126508     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01735.x     Document Type: Article

References (53)

1. Rowe AW. Cryopreservation of red blood cells. Vox Sang 1994 67 : 201 6.
2. American Association of Blood Banks technical manual. 11th ed. Bethesda (MD) : American Association of Blood Banks 2006.
3. Valeri CR, Ragno G. Cryopreservation of human blood products. Transfus Apher Sci 2006 34 : 271 87.
4. Lelkens CC, Noorman F, Koning JG, Truijens-de Lange R, Stekkinger PS, Bakker JC, Lagerberg JW, Brand A, Verhoeven AJ. Stability after thawing of RBCs frozen with the high- and low-glycerol method. Transfusion 2003 43 : 157 64.
5. Valeri CR, Runck AH. Long term frozen storage of human red blood cells: studies in vivo and in vitro of autologous red blood cells preserved up to six years with high concentration of glycerol. Transfusion 1969 9 : 5 14.
6. Valeri CR, Ragno G, Pivacek LE, Cassidy GP, Srey R, Hansson-Wicher M, Leavy ME. An experiment with glycerol-frozen red blood cells stored at -80 degrees C for up to 37 years. Vox Sang 2000 79 : 168 74.
7. Valeri CR, Pivacek LE, Cassidy GP, Ragno G. In vitro and in vivo measurements of human RBCs frozen with glycerol and subjected to various storage temperatures before deglycerolization and storage at 4 degrees C for 3 days. Transfusion 2001 41 : 401 5.
8. Valeri CR. Status report on the quality of liquid and frozen red blood cells. Vox Sang 2002 83 : 193 6.
9. Umlas J, Jacobson M, Kevy SV. Suitable survival and half-life of red cells after frozen storage in excess of 10 years. Transfusion 1991 31 : 648 9.
10. Holme S. Current issues related to the quality of stored RBCs. Transfus Apher Sci 2005 33 : 55 61.
11. Haynes LL, Tullis JL, Pyle HM, Sproul MT, Wallach S, Turwille WC. Clinical use of glycerolized frozen blood. JAMA 1960 173 : 1657 63.
12. Huggins CE. Frozen blood: principles of practical preservation. Monogr Surg Sci 1966 3 : 133 73.
13. Meryman HT, Hornblower M. A method for freezing and washing red blood cells using a high glycerol concentration. Transfusion 1972 12 : 145 56.
14. Valeri CR. New developments in red blood cell preservaton using liquid and freezing procedures. J Lab Clin Med 1982 2 : 425 39.
15. Hogman CF, Meryman HT. Red blood cells intended for transfusion: quality criteria revisited. Transfusion 2006 46 : 137 42.
16. Wolfe LC. The membrane and the lesions of storage in preserved red blood cells. Transfusion 1985 25 : 185 203.
17. Hess JR. An update on solutions for red cell storage. Vox Sang 2006 91 : 13 9.
18. Bessos H, Seghatchian J. Red cell storage lesion: the potential impact of storage-induced CD47 decline on immunomodulation and the survival of leucofiltered red cells. Transfus Apher Sci 2005 32 : 227 32.
19. Bratosin D, Mazurier J, Tissier JP, Estaquier J, Huart JJ, Ameisen JC, Aminoff D, Montreuil J. Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. Biochimie 1998 80 : 173 95.
20. Hogman CF, Meryman HT. Storage parameters affecting red blood cell survival and function after transfusion. Transfus Med Rev 1999 13 : 275 96.
21. De Korte D, Verhoeven AJ. Quality determinants of erythrocyte destined for transfusion. Cell Mol Biol 2004 50 : 187 95.
22. Stewart A, Urbaniak S, Turner M, Bessos H. The application of a new quantitative assay for the monitoring of integrin-associated protein CD47 on red blood cells during storage and comparison with the expression of CD47 and phosphatidylserine with flow cytometry. Transfusion 2005 45 : 1496 503.
23. Anniss AM, Sparrow RL. Expression of CD47 (integrin-associated protein) decreases on red blood cells during storage. Transfus Apher Sci 2002 27 : 233 8.
24. Chin-Yee I, Arya N, d'Almeida MS. The red cell storage lesion and its implication for transfusion. Transfus Sci 1997 18 : 447 58.
25. Head DJ, Lee ZE, Swallah MM, Avent ND. Ligation of CD47 mediates phosphatidylserine expression on erythrocytes and a concomitant loss of viability in vitro. Br J Haematol 2005 130 : 788 90.
26. Sparrow R, Healey G. Reduced expression of CD47 on stored red blood cells. Transfusion 2006 46 : 1263.
27. Seghatchian J, Krailadsiri P. Red cell storage lesion assessed by the levels of potassium, haemoglobin and Annexin V in supernatants. Transfus Apher Sci 2002 26 : 139 43.
28. Freyssinet JM. Cellular microparticles: what are they bad or good for? J Thromb Haemost 2003 1 : 1655 62.
29. Greenwalt TJ. The how and why of exocytic vesicles. Transfusion 2006 46 : 143 52.
30. Europe Co. Guide to the preparation, use and quality assurance of blood components. 13nd ed. Strasbourg : Europe Co. 2007.
31. Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, Ernst JD, Lubin BH. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood 1996 87 : 1179 87.
32. Sparrow RL, Healey G, Patton KA, Veale MF. Red blood cell age determines the impact of storage and leukocyte burden on cell adhesion molecules, glycophorin A and the release of annexin V. Transfus Apher Sci 2006 34 : 15 23.
33. Khandelwal S, van Rooijen N, Saxena RK. Reduced expression of CD47 during murine red blood cell (RBC) senescence and its role in RBC clearance from the circulation. Transfusion 2007 47 : 1725 32.
34. Oldenborg P, Zheleznyak A, Fang Y, Lagenaur CF, Gresham HD, Lindenberg FP. Role of CD47 as a marker of self on red blood cells. Science 2000 288 : 2051 4.
35. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006 20 : 1 26.
36. Zwart A, van Assendelft OW, Bull BS, England JM, Lewis SM, Zilstra WG. Recommendations for reference method for haemoglobinometry in human blood and specifications for international haemoglobincyanide standard. J Clin Pathol 1996 49 : 271 4.
37. Usry R, Moore G, Manalo F. Morphology of stored, rejuvenated human erythrocytes. Vox Sang 1975 28 : 176 83.
38. Umlas J, O'Neill TP. Use of refractive index to measure the adequacy of glycerol removal from previoulsy frozen erythrocytes. Transfusion 1980 20 : 720 4.
39. Zwart A, van Assendelft OW, Bull BS, England JM, Lewis SM, Zijlstra WG. Recommendations for reference method for haemoglobinometry in human blood and specifications for international haemoglobincyanide standard. J Clin Pathol 1996 49 : 271 4.
40. Thomas E, Webb-Young G, Barth C, Alport EC, Kanchana MV. A reliable method to detect bacterial contamination of blood components using an automated blood culture system. Eur J Clin Microbiol Infect Dis 2005 24 : 159 61.
41. Lecak J, Scott K, Young C, Hannon J, Acker JP. Evaluation of red blood cells stored at -80 degrees C in excess of 10 years. Transfusion 2004 44 : 1306 13.
42. Valeri CR, Pivacek LE, Gray AD, Cassidy GP, Leavy ME, Dennis RC, Melaragno AJ, Niehoff J, Yeston N, Emerson CP, Altschule MD. The safety and therapeutic effectiveness of human red cells stored at -80 degrees C for as long as 21 years. Transfusion 1989 29 : 429 37.
43. Valeri CR, Ragno G, Pivacek L, O'Neill EM. In vivo survival of apheresis RBCs, frozen with 40-percent (wt/Volume) glycerol, deglycerolized in the ACP 215, and stored at 4 degrees C in AS-3 for up to 21 days. Transfusion 2001 41 : 928 32.
44. Valeri CR, Ragno G, Pivacek LE, Srey R, Hess JR, Lippert LE, Mettille F, Fahie R, O'Neill EM, Szymanski IO. A multicenter study of in vitro and in vivo values in human RBCs frozen with 40-percent (wt/volume) glycerol and stored after deglycerolization for 15 days at 4 degrees C in AS-3: assessment of RBC processing in the ACP 215. Transfusion 2001 41 : 933 9.
45. Tinmouth A, Chin-Yee I. The clinical consequences of the red cell storage lesion. Transfus Med Rev 2001 15 : 91 107.
46. Andrews DA, Low PS. Role of red blood cells in thrombosis. Curr Opin Hematol 1999 6 : 76 82.
47. Chung S-M, Bae O-N, Lim K-M, Noh J-Y, Lee M-Y, Jung Y-S, Chung J-H. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol 2007 27 : 414 21.
48. Schlegel RA, Williamson P. Phosphatidylserine, a death knell. Cell Death Differ 2001 8 : 551 63.
49. Ahn YS, Jy W, Jimenez JJ, Horstman LL. More on: cellular microparticles: what are they bad or good for? J Thromb Haemost 2004 2 : 1215 6.
50. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003 59 : 277 87.
51. Lecak J, Scott K, Acker JP. Status report on the red blood cell cryopreservation program in Canada. Transfusion 2005 45 : 80A 1A.
52. Lecak J, Scott K, Young C, Acker JP. Frozen blood utilization in Canada. Can Soc Tran Med Bull 2004 16 : 32.
53. Lecak J, Acker JP. Implications of current cryopreservation practices on red blood cell 2,3-DPG levels. Exp Clin Cardol 2004 9 : 99A.